NCT05696899

Determining the Efficacy of Essential Oil Aromatherapy in Children Undergoing Port Access

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 23 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 4 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine if the use of aromatherapy impacts patient anxiety and pain scores surrounding port access in pediatric oncology patients between the ages of 4 years and 18 years.

Detailed description

Specific aims include the following: Aim 1: To compare pre and post port access anxiety scores for both control and intervention groups. Aim 2: To assess pre and post port pain scores surrounding port access for both control and intervention groups. Aim 3: To compare pain and anxiety scores between age groups. The overall goal of this pilot study is to identify if aromatherapy, using non-topical, STILL QuickTAB Medipack blended scent aromatherapy, manufactured by Soothing Scents, is effective as a valid non-pharmacologic supplementation in reducing anxiety and pain scores during port access in pediatric oncology patients.

Conditions

• Anxiety and Fear
• Pain

Interventions

Type	Name	Description
OTHER	STILL QuickTAB Medipack blended scent aromatherapy, manufactured by Soothing Scents	A resealable quick-tab dispenser with the 'therapeutic inhaled essential oils' lavender, bergamot, sweet orange, and ylang ylang.

Timeline

• Start date: 2023-12-05
• Primary completion: 2024-05-30
• Completion: 2024-05-30
• First posted: 2023-01-25
• Last updated: 2024-12-13

Locations

1 site across 1 country: United States